nodes	percent_of_prediction	percent_of_DWPC	metapath
Penicillamine—SLCO1B1—Irinotecan—stomach cancer	0.438	0.654	CbGbCtD
Penicillamine—SLCO1B1—Methotrexate—stomach cancer	0.232	0.346	CbGbCtD
Penicillamine—Haemorrhage—Irinotecan—stomach cancer	0.000932	0.00283	CcSEcCtD
Penicillamine—Agranulocytosis—Fluorouracil—stomach cancer	0.000928	0.00282	CcSEcCtD
Penicillamine—Extravasation—Doxorubicin—stomach cancer	0.000917	0.00279	CcSEcCtD
Penicillamine—Nausea—Mitomycin—stomach cancer	0.000905	0.00275	CcSEcCtD
Penicillamine—Haemoglobin—Fluorouracil—stomach cancer	0.000897	0.00272	CcSEcCtD
Penicillamine—Haemorrhage—Fluorouracil—stomach cancer	0.000892	0.00271	CcSEcCtD
Penicillamine—Glossitis—Doxorubicin—stomach cancer	0.000869	0.00264	CcSEcCtD
Penicillamine—Aplastic anaemia—Methotrexate—stomach cancer	0.000868	0.00263	CcSEcCtD
Penicillamine—Abdominal pain upper—Docetaxel—stomach cancer	0.00085	0.00258	CcSEcCtD
Penicillamine—Angiopathy—Irinotecan—stomach cancer	0.000845	0.00257	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Docetaxel—stomach cancer	0.000838	0.00255	CcSEcCtD
Penicillamine—Mouth ulceration—Methotrexate—stomach cancer	0.000836	0.00254	CcSEcCtD
Penicillamine—Alopecia—Irinotecan—stomach cancer	0.000823	0.0025	CcSEcCtD
Penicillamine—Abdominal pain upper—Capecitabine—stomach cancer	0.000823	0.0025	CcSEcCtD
Penicillamine—Aplastic anaemia—Epirubicin—stomach cancer	0.000812	0.00247	CcSEcCtD
Penicillamine—Neuropathy—Epirubicin—stomach cancer	0.000812	0.00247	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Capecitabine—stomach cancer	0.000812	0.00246	CcSEcCtD
Penicillamine—Muscular weakness—Capecitabine—stomach cancer	0.000795	0.00241	CcSEcCtD
Penicillamine—Alopecia—Fluorouracil—stomach cancer	0.000789	0.00239	CcSEcCtD
Penicillamine—Lymphadenopathy—Methotrexate—stomach cancer	0.000787	0.00239	CcSEcCtD
Penicillamine—Mouth ulceration—Epirubicin—stomach cancer	0.000782	0.00237	CcSEcCtD
Penicillamine—Asthma—Capecitabine—stomach cancer	0.000779	0.00237	CcSEcCtD
Penicillamine—Thrombophlebitis—Methotrexate—stomach cancer	0.000775	0.00235	CcSEcCtD
Penicillamine—Pancytopenia—Docetaxel—stomach cancer	0.000764	0.00232	CcSEcCtD
Penicillamine—Aplastic anaemia—Doxorubicin—stomach cancer	0.000752	0.00228	CcSEcCtD
Penicillamine—Neuropathy—Doxorubicin—stomach cancer	0.000752	0.00228	CcSEcCtD
Penicillamine—Anaemia—Irinotecan—stomach cancer	0.00075	0.00228	CcSEcCtD
Penicillamine—Hepatic failure—Methotrexate—stomach cancer	0.000747	0.00227	CcSEcCtD
Penicillamine—Pancytopenia—Capecitabine—stomach cancer	0.00074	0.00225	CcSEcCtD
Penicillamine—Lymphadenopathy—Epirubicin—stomach cancer	0.000736	0.00223	CcSEcCtD
Penicillamine—Leukopenia—Irinotecan—stomach cancer	0.000726	0.0022	CcSEcCtD
Penicillamine—Thrombophlebitis—Epirubicin—stomach cancer	0.000725	0.0022	CcSEcCtD
Penicillamine—Mouth ulceration—Doxorubicin—stomach cancer	0.000724	0.0022	CcSEcCtD
Penicillamine—Blood alkaline phosphatase increased—Epirubicin—stomach cancer	0.000722	0.00219	CcSEcCtD
Penicillamine—Hepatic function abnormal—Epirubicin—stomach cancer	0.000719	0.00218	CcSEcCtD
Penicillamine—Anaemia—Fluorouracil—stomach cancer	0.000718	0.00218	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Methotrexate—stomach cancer	0.000711	0.00216	CcSEcCtD
Penicillamine—Renal failure—Docetaxel—stomach cancer	0.000705	0.00214	CcSEcCtD
Penicillamine—Neuropathy peripheral—Docetaxel—stomach cancer	0.000703	0.00214	CcSEcCtD
Penicillamine—Stomatitis—Docetaxel—stomach cancer	0.000699	0.00212	CcSEcCtD
Penicillamine—Hepatic failure—Epirubicin—stomach cancer	0.000699	0.00212	CcSEcCtD
Penicillamine—Leukopenia—Fluorouracil—stomach cancer	0.000695	0.00211	CcSEcCtD
Penicillamine—Renal failure—Capecitabine—stomach cancer	0.000683	0.00207	CcSEcCtD
Penicillamine—Lymphadenopathy—Doxorubicin—stomach cancer	0.000681	0.00207	CcSEcCtD
Penicillamine—Neuropathy peripheral—Capecitabine—stomach cancer	0.000681	0.00207	CcSEcCtD
Penicillamine—Hepatobiliary disease—Docetaxel—stomach cancer	0.000679	0.00206	CcSEcCtD
Penicillamine—Stomatitis—Capecitabine—stomach cancer	0.000677	0.00206	CcSEcCtD
Penicillamine—Thrombophlebitis—Doxorubicin—stomach cancer	0.000671	0.00204	CcSEcCtD
Penicillamine—Agranulocytosis—Docetaxel—stomach cancer	0.00067	0.00203	CcSEcCtD
Penicillamine—Blood alkaline phosphatase increased—Doxorubicin—stomach cancer	0.000668	0.00203	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Epirubicin—stomach cancer	0.000666	0.00202	CcSEcCtD
Penicillamine—Hepatic function abnormal—Doxorubicin—stomach cancer	0.000665	0.00202	CcSEcCtD
Penicillamine—Haematuria—Capecitabine—stomach cancer	0.000662	0.00201	CcSEcCtD
Penicillamine—Hepatobiliary disease—Capecitabine—stomach cancer	0.000657	0.00199	CcSEcCtD
Penicillamine—Agranulocytosis—Capecitabine—stomach cancer	0.000648	0.00197	CcSEcCtD
Penicillamine—Thrombocytopenia—Irinotecan—stomach cancer	0.000648	0.00197	CcSEcCtD
Penicillamine—Haemoglobin—Docetaxel—stomach cancer	0.000647	0.00197	CcSEcCtD
Penicillamine—Hepatic failure—Doxorubicin—stomach cancer	0.000647	0.00196	CcSEcCtD
Penicillamine—Haemorrhage—Docetaxel—stomach cancer	0.000644	0.00196	CcSEcCtD
Penicillamine—Hypoglycaemia—Epirubicin—stomach cancer	0.000643	0.00195	CcSEcCtD
Penicillamine—Urinary tract disorder—Docetaxel—stomach cancer	0.000636	0.00193	CcSEcCtD
Penicillamine—Urethral disorder—Docetaxel—stomach cancer	0.000631	0.00192	CcSEcCtD
Penicillamine—Anorexia—Irinotecan—stomach cancer	0.000631	0.00192	CcSEcCtD
Penicillamine—Haemoglobin—Capecitabine—stomach cancer	0.000627	0.0019	CcSEcCtD
Penicillamine—Haemorrhage—Capecitabine—stomach cancer	0.000624	0.00189	CcSEcCtD
Penicillamine—Thrombocytopenia—Fluorouracil—stomach cancer	0.000621	0.00188	CcSEcCtD
Penicillamine—Urinary tract disorder—Capecitabine—stomach cancer	0.000616	0.00187	CcSEcCtD
Penicillamine—Dermatitis exfoliative—Doxorubicin—stomach cancer	0.000616	0.00187	CcSEcCtD
Penicillamine—Urethral disorder—Capecitabine—stomach cancer	0.000611	0.00186	CcSEcCtD
Penicillamine—Anorexia—Fluorouracil—stomach cancer	0.000604	0.00183	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Methotrexate—stomach cancer	0.000604	0.00183	CcSEcCtD
Penicillamine—Hypoglycaemia—Doxorubicin—stomach cancer	0.000595	0.00181	CcSEcCtD
Penicillamine—Angiopathy—Docetaxel—stomach cancer	0.000584	0.00177	CcSEcCtD
Penicillamine—Tinnitus—Capecitabine—stomach cancer	0.000581	0.00177	CcSEcCtD
Penicillamine—Asthma—Methotrexate—stomach cancer	0.00058	0.00176	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Fluorouracil—stomach cancer	0.000578	0.00175	CcSEcCtD
Penicillamine—Decreased appetite—Irinotecan—stomach cancer	0.000575	0.00175	CcSEcCtD
Penicillamine—Eosinophilia—Methotrexate—stomach cancer	0.000574	0.00174	CcSEcCtD
Penicillamine—Abdominal pain upper—Epirubicin—stomach cancer	0.000574	0.00174	CcSEcCtD
Penicillamine—Alopecia—Docetaxel—stomach cancer	0.000569	0.00173	CcSEcCtD
Penicillamine—Pancreatitis—Methotrexate—stomach cancer	0.000569	0.00173	CcSEcCtD
Penicillamine—Angiopathy—Capecitabine—stomach cancer	0.000566	0.00172	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Epirubicin—stomach cancer	0.000566	0.00172	CcSEcCtD
Penicillamine—Mental disorder—Docetaxel—stomach cancer	0.000564	0.00171	CcSEcCtD
Penicillamine—Muscular weakness—Epirubicin—stomach cancer	0.000554	0.00168	CcSEcCtD
Penicillamine—Decreased appetite—Fluorouracil—stomach cancer	0.000551	0.00167	CcSEcCtD
Penicillamine—Alopecia—Capecitabine—stomach cancer	0.000551	0.00167	CcSEcCtD
Penicillamine—Pancytopenia—Methotrexate—stomach cancer	0.000551	0.00167	CcSEcCtD
Penicillamine—Dysgeusia—Docetaxel—stomach cancer	0.000549	0.00167	CcSEcCtD
Penicillamine—Mental disorder—Capecitabine—stomach cancer	0.000546	0.00166	CcSEcCtD
Penicillamine—Asthma—Epirubicin—stomach cancer	0.000543	0.00165	CcSEcCtD
Penicillamine—Eosinophilia—Epirubicin—stomach cancer	0.000537	0.00163	CcSEcCtD
Penicillamine—Pancreatitis—Epirubicin—stomach cancer	0.000532	0.00162	CcSEcCtD
Penicillamine—Dysgeusia—Capecitabine—stomach cancer	0.000532	0.00161	CcSEcCtD
Penicillamine—Abdominal pain upper—Doxorubicin—stomach cancer	0.000531	0.00161	CcSEcCtD
Penicillamine—Body temperature increased—Irinotecan—stomach cancer	0.000523	0.00159	CcSEcCtD
Penicillamine—Toxic epidermal necrolysis—Doxorubicin—stomach cancer	0.000523	0.00159	CcSEcCtD
Penicillamine—Anaemia—Docetaxel—stomach cancer	0.000518	0.00157	CcSEcCtD
Penicillamine—Pancytopenia—Epirubicin—stomach cancer	0.000515	0.00156	CcSEcCtD
Penicillamine—Muscular weakness—Doxorubicin—stomach cancer	0.000512	0.00156	CcSEcCtD
Penicillamine—Renal failure—Methotrexate—stomach cancer	0.000508	0.00154	CcSEcCtD
Penicillamine—Stomatitis—Methotrexate—stomach cancer	0.000504	0.00153	CcSEcCtD
Penicillamine—Urticaria—Fluorouracil—stomach cancer	0.000504	0.00153	CcSEcCtD
Penicillamine—Asthma—Doxorubicin—stomach cancer	0.000502	0.00152	CcSEcCtD
Penicillamine—Leukopenia—Docetaxel—stomach cancer	0.000502	0.00152	CcSEcCtD
Penicillamine—Anaemia—Capecitabine—stomach cancer	0.000502	0.00152	CcSEcCtD
Penicillamine—Body temperature increased—Fluorouracil—stomach cancer	0.000501	0.00152	CcSEcCtD
Penicillamine—Eosinophilia—Doxorubicin—stomach cancer	0.000497	0.00151	CcSEcCtD
Penicillamine—Haematuria—Methotrexate—stomach cancer	0.000493	0.0015	CcSEcCtD
Penicillamine—Pancreatitis—Doxorubicin—stomach cancer	0.000492	0.00149	CcSEcCtD
Penicillamine—Hepatobiliary disease—Methotrexate—stomach cancer	0.000489	0.00148	CcSEcCtD
Penicillamine—Hypersensitivity—Irinotecan—stomach cancer	0.000488	0.00148	CcSEcCtD
Penicillamine—Leukopenia—Capecitabine—stomach cancer	0.000486	0.00148	CcSEcCtD
Penicillamine—Agranulocytosis—Methotrexate—stomach cancer	0.000483	0.00146	CcSEcCtD
Penicillamine—Arthralgia—Docetaxel—stomach cancer	0.000477	0.00145	CcSEcCtD
Penicillamine—Pancytopenia—Doxorubicin—stomach cancer	0.000477	0.00145	CcSEcCtD
Penicillamine—Renal failure—Epirubicin—stomach cancer	0.000476	0.00144	CcSEcCtD
Penicillamine—Neuropathy peripheral—Epirubicin—stomach cancer	0.000474	0.00144	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—stomach cancer	0.000474	0.00144	CcSEcCtD
Penicillamine—Stomatitis—Epirubicin—stomach cancer	0.000472	0.00143	CcSEcCtD
Penicillamine—Hypersensitivity—Fluorouracil—stomach cancer	0.000467	0.00142	CcSEcCtD
Penicillamine—Haemoglobin—Methotrexate—stomach cancer	0.000467	0.00142	CcSEcCtD
Penicillamine—Haemorrhage—Methotrexate—stomach cancer	0.000464	0.00141	CcSEcCtD
Penicillamine—Arthralgia—Capecitabine—stomach cancer	0.000462	0.0014	CcSEcCtD
Penicillamine—Haematuria—Epirubicin—stomach cancer	0.000461	0.0014	CcSEcCtD
Penicillamine—Anxiety—Capecitabine—stomach cancer	0.000461	0.0014	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—stomach cancer	0.000459	0.00139	CcSEcCtD
Penicillamine—Urinary tract disorder—Methotrexate—stomach cancer	0.000458	0.00139	CcSEcCtD
Penicillamine—Hepatobiliary disease—Epirubicin—stomach cancer	0.000458	0.00139	CcSEcCtD
Penicillamine—Urethral disorder—Methotrexate—stomach cancer	0.000455	0.00138	CcSEcCtD
Penicillamine—Diarrhoea—Irinotecan—stomach cancer	0.000453	0.00137	CcSEcCtD
Penicillamine—Agranulocytosis—Epirubicin—stomach cancer	0.000452	0.00137	CcSEcCtD
Penicillamine—Thrombocytopenia—Docetaxel—stomach cancer	0.000448	0.00136	CcSEcCtD
Penicillamine—Skin disorder—Docetaxel—stomach cancer	0.000444	0.00135	CcSEcCtD
Penicillamine—Renal failure—Doxorubicin—stomach cancer	0.00044	0.00134	CcSEcCtD
Penicillamine—Neuropathy peripheral—Doxorubicin—stomach cancer	0.000439	0.00133	CcSEcCtD
Penicillamine—Haemoglobin—Epirubicin—stomach cancer	0.000437	0.00133	CcSEcCtD
Penicillamine—Stomatitis—Doxorubicin—stomach cancer	0.000436	0.00132	CcSEcCtD
Penicillamine—Anorexia—Docetaxel—stomach cancer	0.000436	0.00132	CcSEcCtD
Penicillamine—Haemorrhage—Epirubicin—stomach cancer	0.000434	0.00132	CcSEcCtD
Penicillamine—Diarrhoea—Fluorouracil—stomach cancer	0.000434	0.00132	CcSEcCtD
Penicillamine—Thrombocytopenia—Capecitabine—stomach cancer	0.000434	0.00132	CcSEcCtD
Penicillamine—Tinnitus—Methotrexate—stomach cancer	0.000433	0.00131	CcSEcCtD
Penicillamine—Skin disorder—Capecitabine—stomach cancer	0.00043	0.00131	CcSEcCtD
Penicillamine—Urinary tract disorder—Epirubicin—stomach cancer	0.000429	0.0013	CcSEcCtD
Penicillamine—Haematuria—Doxorubicin—stomach cancer	0.000427	0.0013	CcSEcCtD
Penicillamine—Urethral disorder—Epirubicin—stomach cancer	0.000426	0.00129	CcSEcCtD
Penicillamine—Hepatobiliary disease—Doxorubicin—stomach cancer	0.000423	0.00129	CcSEcCtD
Penicillamine—Anorexia—Capecitabine—stomach cancer	0.000422	0.00128	CcSEcCtD
Penicillamine—Angiopathy—Methotrexate—stomach cancer	0.000421	0.00128	CcSEcCtD
Penicillamine—Vomiting—Irinotecan—stomach cancer	0.000421	0.00128	CcSEcCtD
Penicillamine—Agranulocytosis—Doxorubicin—stomach cancer	0.000418	0.00127	CcSEcCtD
Penicillamine—Rash—Irinotecan—stomach cancer	0.000417	0.00127	CcSEcCtD
Penicillamine—Dermatitis—Irinotecan—stomach cancer	0.000417	0.00127	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Docetaxel—stomach cancer	0.000417	0.00127	CcSEcCtD
Penicillamine—Alopecia—Methotrexate—stomach cancer	0.00041	0.00125	CcSEcCtD
Penicillamine—Mental disorder—Methotrexate—stomach cancer	0.000407	0.00123	CcSEcCtD
Penicillamine—Tinnitus—Epirubicin—stomach cancer	0.000405	0.00123	CcSEcCtD
Penicillamine—Haemoglobin—Doxorubicin—stomach cancer	0.000404	0.00123	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Capecitabine—stomach cancer	0.000404	0.00123	CcSEcCtD
Penicillamine—Vomiting—Fluorouracil—stomach cancer	0.000403	0.00122	CcSEcCtD
Penicillamine—Haemorrhage—Doxorubicin—stomach cancer	0.000402	0.00122	CcSEcCtD
Penicillamine—Rash—Fluorouracil—stomach cancer	0.0004	0.00121	CcSEcCtD
Penicillamine—Dermatitis—Fluorouracil—stomach cancer	0.000399	0.00121	CcSEcCtD
Penicillamine—Decreased appetite—Docetaxel—stomach cancer	0.000398	0.00121	CcSEcCtD
Penicillamine—Urinary tract disorder—Doxorubicin—stomach cancer	0.000397	0.00121	CcSEcCtD
Penicillamine—Dysgeusia—Methotrexate—stomach cancer	0.000396	0.0012	CcSEcCtD
Penicillamine—Angiopathy—Epirubicin—stomach cancer	0.000394	0.0012	CcSEcCtD
Penicillamine—Urethral disorder—Doxorubicin—stomach cancer	0.000394	0.0012	CcSEcCtD
Penicillamine—Nausea—Irinotecan—stomach cancer	0.000393	0.00119	CcSEcCtD
Penicillamine—Decreased appetite—Capecitabine—stomach cancer	0.000385	0.00117	CcSEcCtD
Penicillamine—Alopecia—Epirubicin—stomach cancer	0.000384	0.00117	CcSEcCtD
Penicillamine—Mental disorder—Epirubicin—stomach cancer	0.000381	0.00116	CcSEcCtD
Penicillamine—Nausea—Fluorouracil—stomach cancer	0.000377	0.00114	CcSEcCtD
Penicillamine—Tinnitus—Doxorubicin—stomach cancer	0.000375	0.00114	CcSEcCtD
Penicillamine—Anaemia—Methotrexate—stomach cancer	0.000374	0.00113	CcSEcCtD
Penicillamine—Dysgeusia—Epirubicin—stomach cancer	0.00037	0.00112	CcSEcCtD
Penicillamine—Angiopathy—Doxorubicin—stomach cancer	0.000365	0.00111	CcSEcCtD
Penicillamine—Body temperature increased—Docetaxel—stomach cancer	0.000362	0.0011	CcSEcCtD
Penicillamine—Leukopenia—Methotrexate—stomach cancer	0.000362	0.0011	CcSEcCtD
Penicillamine—Alopecia—Doxorubicin—stomach cancer	0.000355	0.00108	CcSEcCtD
Penicillamine—Mental disorder—Doxorubicin—stomach cancer	0.000352	0.00107	CcSEcCtD
Penicillamine—Urticaria—Capecitabine—stomach cancer	0.000352	0.00107	CcSEcCtD
Penicillamine—Body temperature increased—Capecitabine—stomach cancer	0.00035	0.00106	CcSEcCtD
Penicillamine—Anaemia—Epirubicin—stomach cancer	0.00035	0.00106	CcSEcCtD
Penicillamine—Agitation—Epirubicin—stomach cancer	0.000348	0.00106	CcSEcCtD
Penicillamine—Arthralgia—Methotrexate—stomach cancer	0.000344	0.00104	CcSEcCtD
Penicillamine—Dysgeusia—Doxorubicin—stomach cancer	0.000343	0.00104	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	0.000342	0.00104	CcSEcCtD
Penicillamine—Leukopenia—Epirubicin—stomach cancer	0.000339	0.00103	CcSEcCtD
Penicillamine—Hypersensitivity—Docetaxel—stomach cancer	0.000337	0.00102	CcSEcCtD
Penicillamine—Hypersensitivity—Capecitabine—stomach cancer	0.000326	0.000991	CcSEcCtD
Penicillamine—Anaemia—Doxorubicin—stomach cancer	0.000323	0.000982	CcSEcCtD
Penicillamine—Thrombocytopenia—Methotrexate—stomach cancer	0.000323	0.00098	CcSEcCtD
Penicillamine—Arthralgia—Epirubicin—stomach cancer	0.000322	0.000977	CcSEcCtD
Penicillamine—Agitation—Doxorubicin—stomach cancer	0.000322	0.000976	CcSEcCtD
Penicillamine—Anxiety—Epirubicin—stomach cancer	0.000321	0.000974	CcSEcCtD
Penicillamine—Skin disorder—Methotrexate—stomach cancer	0.00032	0.000973	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	0.00032	0.000971	CcSEcCtD
Penicillamine—Anorexia—Methotrexate—stomach cancer	0.000314	0.000954	CcSEcCtD
Penicillamine—Leukopenia—Doxorubicin—stomach cancer	0.000313	0.000951	CcSEcCtD
Penicillamine—Diarrhoea—Docetaxel—stomach cancer	0.000313	0.00095	CcSEcCtD
Penicillamine—Diarrhoea—Capecitabine—stomach cancer	0.000303	0.00092	CcSEcCtD
Penicillamine—Thrombocytopenia—Epirubicin—stomach cancer	0.000302	0.000917	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Methotrexate—stomach cancer	0.0003	0.000912	CcSEcCtD
Penicillamine—Skin disorder—Epirubicin—stomach cancer	0.0003	0.00091	CcSEcCtD
Penicillamine—Arthralgia—Doxorubicin—stomach cancer	0.000298	0.000904	CcSEcCtD
Penicillamine—Anxiety—Doxorubicin—stomach cancer	0.000297	0.000901	CcSEcCtD
Penicillamine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	0.000296	0.000898	CcSEcCtD
Penicillamine—Anorexia—Epirubicin—stomach cancer	0.000294	0.000893	CcSEcCtD
Penicillamine—Vomiting—Docetaxel—stomach cancer	0.000291	0.000883	CcSEcCtD
Penicillamine—Rash—Docetaxel—stomach cancer	0.000289	0.000876	CcSEcCtD
Penicillamine—Dermatitis—Docetaxel—stomach cancer	0.000288	0.000875	CcSEcCtD
Penicillamine—Decreased appetite—Methotrexate—stomach cancer	0.000287	0.00087	CcSEcCtD
Penicillamine—Vomiting—Capecitabine—stomach cancer	0.000282	0.000855	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Epirubicin—stomach cancer	0.000281	0.000854	CcSEcCtD
Penicillamine—Thrombocytopenia—Doxorubicin—stomach cancer	0.00028	0.000849	CcSEcCtD
Penicillamine—Rash—Capecitabine—stomach cancer	0.000279	0.000848	CcSEcCtD
Penicillamine—Dermatitis—Capecitabine—stomach cancer	0.000279	0.000847	CcSEcCtD
Penicillamine—Skin disorder—Doxorubicin—stomach cancer	0.000277	0.000842	CcSEcCtD
Penicillamine—Anorexia—Doxorubicin—stomach cancer	0.000272	0.000826	CcSEcCtD
Penicillamine—Nausea—Docetaxel—stomach cancer	0.000272	0.000825	CcSEcCtD
Penicillamine—Decreased appetite—Epirubicin—stomach cancer	0.000268	0.000815	CcSEcCtD
Penicillamine—Nausea—Capecitabine—stomach cancer	0.000263	0.000799	CcSEcCtD
Penicillamine—Urticaria—Methotrexate—stomach cancer	0.000262	0.000795	CcSEcCtD
Penicillamine—Body temperature increased—Methotrexate—stomach cancer	0.000261	0.000791	CcSEcCtD
Penicillamine—Musculoskeletal discomfort—Doxorubicin—stomach cancer	0.00026	0.00079	CcSEcCtD
Penicillamine—Decreased appetite—Doxorubicin—stomach cancer	0.000248	0.000754	CcSEcCtD
Penicillamine—Urticaria—Epirubicin—stomach cancer	0.000245	0.000744	CcSEcCtD
Penicillamine—Body temperature increased—Epirubicin—stomach cancer	0.000244	0.000741	CcSEcCtD
Penicillamine—Hypersensitivity—Methotrexate—stomach cancer	0.000243	0.000738	CcSEcCtD
Penicillamine—Hypersensitivity—Epirubicin—stomach cancer	0.000227	0.00069	CcSEcCtD
Penicillamine—Urticaria—Doxorubicin—stomach cancer	0.000227	0.000689	CcSEcCtD
Penicillamine—Body temperature increased—Doxorubicin—stomach cancer	0.000226	0.000685	CcSEcCtD
Penicillamine—Diarrhoea—Methotrexate—stomach cancer	0.000226	0.000685	CcSEcCtD
Penicillamine—Diarrhoea—Epirubicin—stomach cancer	0.000211	0.000641	CcSEcCtD
Penicillamine—Hypersensitivity—Doxorubicin—stomach cancer	0.00021	0.000639	CcSEcCtD
Penicillamine—Vomiting—Methotrexate—stomach cancer	0.00021	0.000637	CcSEcCtD
Penicillamine—Rash—Methotrexate—stomach cancer	0.000208	0.000631	CcSEcCtD
Penicillamine—Dermatitis—Methotrexate—stomach cancer	0.000208	0.000631	CcSEcCtD
Penicillamine—Vomiting—Epirubicin—stomach cancer	0.000196	0.000596	CcSEcCtD
Penicillamine—Nausea—Methotrexate—stomach cancer	0.000196	0.000595	CcSEcCtD
Penicillamine—Diarrhoea—Doxorubicin—stomach cancer	0.000195	0.000593	CcSEcCtD
Penicillamine—Rash—Epirubicin—stomach cancer	0.000195	0.000591	CcSEcCtD
Penicillamine—Dermatitis—Epirubicin—stomach cancer	0.000194	0.00059	CcSEcCtD
Penicillamine—Nausea—Epirubicin—stomach cancer	0.000183	0.000557	CcSEcCtD
Penicillamine—Vomiting—Doxorubicin—stomach cancer	0.000182	0.000551	CcSEcCtD
Penicillamine—Rash—Doxorubicin—stomach cancer	0.00018	0.000547	CcSEcCtD
Penicillamine—Dermatitis—Doxorubicin—stomach cancer	0.00018	0.000546	CcSEcCtD
Penicillamine—Nausea—Doxorubicin—stomach cancer	0.00017	0.000515	CcSEcCtD
